Your healthcare provider will test your cancer for certain types of abnormal FGFR genes and make sure that BALVERSA® is right for you.
BALVERSA® is not recommended for the treatment of people who are eligible for and have not received prior PD-1 or PD-L1 inhibitor therapy.
It is not known if BALVERSA® is safe and effective in children.
See how BALVERSA® works, clinical trial results, and side effects
How does BALVERSA® work?